OtherNCT06687317
Reliabılıty,Validity Of The Turkish Version Of The KNAP
An observational study of Other, run by Gazi University at 2 sites in Turkey (Türkiye).
Trial summary
This study, we performed the Turkish version validity and reliability of the KNAP Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Other
- What is being tested?
- Behavioral
- How many people
- 300 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 1 Dec 2024to 1 Dec 2025
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Physiotherapy and rehabilitation department students and physiotherapists who speak Turkish
Inclusion Criteria: Physiotherapy and rehabilitation department students and physiotherapists who speak Turkish -
Exclusion Criteria: Physiotherapy and rehabilitation students and physiotherapists who do not speak Turkish.
-
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)2 sites
Gokhan MARAS
Ankara, 06500
Gökhan maraş
Ankara, 06500
About this study
This study, we performed the Turkish version validity and reliability of the KNAP
Read the detailed description
Chronic musculoskeletal pain is significantly affected by the attitudes and beliefs of healthcare professionals and affects patient management outcomes . Adopting a biopsychosocial approach rather than a solely biomedical approach is of great importance in order to comply with current pain management guidelines and reduce both pain levels and disability . Therefore, it is important to recognize healthcare professionals' knowledge, attitudes, and beliefs regarding pain . Pain science education is a powerful strategy to manage chronic musculoskeletal pain by addressing biopsychosocial factors . It improves the understanding of pain by integrating psychological and social aspects beyond anatomical factors and provides better rehabilitation outcomes. Healthcare professionals are crucial to providing effective treatment and patient pain education and require a solid understanding of pain science principles . Many validated surveys assess health care professionals' knowledge and attitudes regarding chronic pain, but they often lack elements of modern pain science and biopsychosocial treatment orientations . To address these limitations, the Knowledge and Attitudes to Pain (KNAP) questionnaire was developed to assess modern pain science and biopsychosocial attitudes toward pain. The KNAP questionnaire consists of 30 items divided into two domains. It is scored using a 6-point Likert scale and has been validated in Brazilian Portuguese, French, Spanish, and Japanese .Therefore, the aim of this study was to adapt the KNAP questionnaire for Turkish physiotherapists and to rigorously examine its psychometric properties among physiotherapy graduates and students in Turkey. The study aims to validate the questionnaire to accurately assess pain knowledge, attitudes, and beliefs by analyzing internal consistency, structural and construct validity, reliability, sensitivity, and interpretability.
- Conditions
- Other
- Being tested
- Behavioral
- Keywords
- Validity, Reliability, Version
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BehavioralOther
Also called Observational
KNAP
What is being measured
The primary outcome is the main question the study is designed to answer.
KNAP
The Knowledge and Attitudes of Pain (KNAP) questionnaire was developed to address these limitations, evaluating the knowledge of modern pain science and biopsychosocial attitudes toward pain
Measured: 10 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2024
- Study start1 Dec 2024 (estimated)
- Primary completion5 Dec 2024 (estimated)
- Study completion1 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OtherStudies of the same condition, open and under way.
- More trials run by Gazi UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 300 participants (estimated)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Gazi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, GÖKHAN MARAŞ, Amasya University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06687317
- Sponsor's protocol ID
- 2024-11
- Status last verified
- Nov 2024
- First submitted
- 12 Nov 2024
- Last updated
- 13 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reliabılıty,Validity Of The Turkish Version Of The KNAP
- ClinicalTrials.gov ID
- NCT06687317
- Acronym / sponsor ID
- 2024-11
- Conditions
- Other
- Keywords
- Validity, Reliability, Version
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Gazi UniversityUniversity, hospital or other
- Study start
- 1 Dec 2024 (estimated)
- Primary completion
- 5 Dec 2024 (estimated)
- Study completion
- 1 Dec 2025 (estimated)
- First posted
- 13 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study, we performed the Turkish version validity and reliability of the KNAP
Detailed description
Chronic musculoskeletal pain is significantly affected by the attitudes and beliefs of healthcare professionals and affects patient management outcomes . Adopting a biopsychosocial approach rather than a solely biomedical approach is of great importance in order to comply with current pain management guidelines and reduce both pain levels and disability . Therefore, it is important to recognize healthcare professionals' knowledge, attitudes, and beliefs regarding pain . Pain science education is a powerful strategy to manage chronic musculoskeletal pain by addressing biopsychosocial factors . It improves the understanding of pain by integrating psychological and social aspects beyond anatomical factors and provides better rehabilitation outcomes. Healthcare professionals are crucial to providing effective treatment and patient pain education and require a solid understanding of pain science principles . Many validated surveys assess health care professionals' knowledge and attitudes regarding chronic pain, but they often lack elements of modern pain science and biopsychosocial treatment orientations . To address these limitations, the Knowledge and Attitudes to Pain (KNAP) questionnaire was developed to assess modern pain science and biopsychosocial attitudes toward pain. The KNAP questionnaire consists of 30 items divided into two domains. It is scored using a 6-point Likert scale and has been validated in Brazilian Portuguese, French, Spanish, and Japanese .Therefore, the aim of this study was to adapt the KNAP questionnaire for Turkish physiotherapists and to rigorously examine its psychometric properties among physiotherapy graduates and students in Turkey. The study aims to validate the questionnaire to accurately assess pain knowledge, attitudes, and beliefs by analyzing internal consistency, structural and construct validity, reliability, sensitivity, and interpretability.
Study design
- Observational model
- Other
- Time perspective
- Other
- Target follow-up
- 1 Month
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Physiotherapy and rehabilitation department students and physiotherapists who speak Turkish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BehavioralAlso: ObservationalKNAP | Other | – |
Primary outcome
KNAP
Time frame: 10 minutes
The Knowledge and Attitudes of Pain (KNAP) questionnaire was developed to address these limitations, evaluating the knowledge of modern pain science and biopsychosocial attitudes toward pain
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Nov 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Other
Active, not recruitingPhase 3
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
Solid Tumors
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Active, not recruitingPhase 1/2
Study of Oral MRT-2359 in Selected Cancer Patients
NSCLC, SCLC
RecruitingPhase 1/2
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Other, run by Gazi University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
KNAP (time frame: 10 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2024.